We are excited to announce that OASYS NOW has successfully raised $1,000,000 in our latest funding round, marking a significant milestone in our mission to democratize personalized healthcare and precision medicine. At OASYS NOW, our multi-disciplinary team combines cutting-edge artificial intelligence and robust cybersecurity measures to ensure the safe and effective reuse of health data. With this new influx of capital, we are poised to enhance our innovative solutions, particularly our leading-edge AI-powered Patient Recruitment platform tailored for clinical trials. Central to our offering are two empowering products: the GRIP app, which puts patients in control of their health data, allowing them to gain personal insights and discover available clinical trials tailored to their conditions, and the ELaiGIBLE platform, designed to expedite the identification of eligible patient cohorts for clinical trials. This remarkable technology reduces the tedious process of patient recruitment from months to just minutes for trial sites, including hospitals, clinics, and contract research organizations (CROs). With the new funding, we aim to accelerate our product development, expand our user base, and ultimately change the way patients access cutting-edge treatments. We believe that with the support of our investors, we are one step closer to transforming the landscape of clinical trials, making them more accessible and efficient for patients and healthcare providers alike.







